SCHEMBL6984638

SCHEMBL6984638

Cc1ccc2cc(NS(=O)(=O)c3ccccc3)ccc2n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.63
LMNA P02545 3/20 0.63
ALDH1A1 P00352 8/20 0.56
NPC1 O15118 4/20 0.56
RAB9A P51151 4/20 0.56
TSHR P16473 1/20 0.54
AGTR1 P30556 1/20 0.53
GLO1 Q04760 1/20 0.53
PAX8 Q06710 1/20 0.53
SLC40A1 Q9NP59 1/20 0.53
KDM1A O60341 1/20 0.53
BRD4 O60885 1/20 0.53
BRD1 O95696 1/20 0.53
BRPF1 P55201 1/20 0.53
BRD9 Q9H8M2 1/20 0.53
BRPF3 Q9ULD4 1/20 0.53
HPGD P15428 4/20 0.52
KDM4E B2RXH2 3/20 0.52
HSD17B10 Q99714 1/20 0.52
PKM P14618 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982624 0.83 ALDH1A1 (0.51) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL5335572 0.82 MAPT (0.57) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL9676236 0.80 NPC1 (0.51) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL28842217 0.79 NPC1 (0.54) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL6985862 0.78 ALDH1A1 (0.78) SMN1; SMN2LMNAALDH1A1NPC1AGTR1
SCHEMBL2614387 0.78 SMN1; SMN2 (1.00) SMN1; SMN2LMNAALDH1A1BRD4BRD1
SCHEMBL17682474 0.77 TSHR (0.70) SMN1; SMN2LMNAALDH1A1TSHRHPGD
SCHEMBL5343689 0.77 HSD11B1 (0.60) SMN1; SMN2LMNAALDH1A1NPC1RAB9A
SCHEMBL14629169 0.76 LMNA (0.71) SMN1; SMN2LMNAALDH1A1BRD4BRD1
SCHEMBL10939039 0.75 KDM1A (0.70) LMNAALDH1A1NPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed